Phenylketonuria

Phenylketonuria (PKU) happens because of changes in the PAH gene that are inherited or occur as a new mutation.
A child is affected when two nonworking copies are inherited, with both parents usually healthy carriers.
Doctors distinguish between risk factors you can change and those you can’t.
Non‑modifiable risk factors for phenylketonuria include having two carrier parents, a family history, certain ancestries or regions with higher rates, and parents who are related by blood.
For people with PKU, modifiable risks for complications include poor control of phenylalanine levels, eating lots of high‑protein foods or aspartame, and unmanaged levels during pregnancy, which can harm a developing baby.

Genetic risk factors

In families affected by phenylketonuria (PKU), the chance of a child being affected depends on specific gene changes inherited from both parents. Some risk factors are inherited through our genes. Most cases come from variants in the PAH gene passed in an autosomal recessive pattern, with rarer forms tied to genes that affect a helper molecule called BH4. These gene differences don’t change how a newborn looks, but they set the stage for early symptoms of phenylketonuria if treatment doesn’t start promptly.

• PAH gene variants: Most cases of PKU are caused by changes in the PAH gene that reduce how well the enzyme breaks down phenylalanine. The specific change can range from mild to severe, which helps explain different PKU severities.

• Autosomal recessive pattern: A child must inherit two nonworking copies of PAH, one from each parent, to develop PKU. Parents with one changed copy are typically healthy carriers.

• Carrier parents: When both parents are carriers, each pregnancy has a 25% chance of PKU, a 50% chance of a carrier child, and a 25% chance of a child with no PAH change. Carrier testing can clarify these odds before or during pregnancy.

• Family history: Having a sibling or close relative with phenylketonuria increases the chance that others in the family are carriers. New PAH changes arising for the first time in a child are uncommon.

• Consanguinity: When parents are related by blood, they are more likely to share the same PAH gene change. This increases the chance of a child with PKU.

• Ancestry patterns: PKU is more common in some populations, including people with Northern European or Turkish ancestry, and less common in some East Asian and sub-Saharan African groups. Rates differ by country and community.

• BH4 pathway genes: Rare forms of high phenylalanine result from changes in genes that make or recycle a helper molecule called BH4. These non-classic forms can look like PKU on screening but need specific testing to confirm.

• Compound heterozygosity: Many people with PKU inherit two different PAH changes rather than identical ones. The milder change often has a strong influence on overall severity.

Transmission

Phenylketonuria (PKU) is a genetic condition, not contagious—you can’t catch it from someone else.

The genetic transmission of Phenylketonuria follows an autosomal recessive pattern, meaning a baby must inherit two non-working copies of the same gene—one from each parent—to have PKU. Parents are usually healthy carriers, and with each pregnancy there’s a 25% (1 in 4) chance the child will have PKU, a 50% (1 in 2) chance the child will be a carrier, and a 25% chance the child will inherit two working copies. In rare cases, PKU can result from a new gene change in the child, but most often both parents carry the change.

When to test your genes

PKU is a genetic condition present from birth, so newborn screening is essential and done routinely in most countries. If you were not screened as a baby or records are unclear, test before pregnancy or as soon as possible to guide diet and prevent complications. Adults with PKU planning pregnancy should test and optimize phenylalanine levels beforehand.

Many living with Phenylketonuria (PKU) can expect a near-normal life span and active daily life when treatment starts early and stays consistent. Early care can make a real difference, especially in preventing the early symptoms of PKU that affect brain development in infants and young children. For most people diagnosed through newborn screening and placed on a low-phenylalanine diet right away, thinking skills, school performance, and growth are typically in a healthy range. Without treatment, PKU can cause severe, permanent learning and movement problems, so staying on plan matters throughout life.

The outlook is not the same for everyone, but most people with PKU do best when they keep blood phenylalanine in the target range. Sticking with the medical diet, using special medical foods, and, for some, adding medications like sapropterin or pegvaliase can widen food choices and improve control. Adults with lifelong treatment generally work, drive, exercise, and raise families; however, lapses in control can bring back issues like brain fog, headaches, low mood, or attention problems. Women with PKU need especially careful control before and during pregnancy to prevent “maternal PKU” effects on the baby, which can cause birth defects and developmental delays if levels stay high.

Prognosis refers to how a condition tends to change or stabilize over time. With good metabolic control, mortality is not increased compared with the general population; deaths related directly to PKU are rare today in countries with newborn screening. In places without screening or treatment access, severe disability and reduced life expectancy can still occur, underscoring the value of lifelong care. Talk with your doctor about what your personal outlook might look like, including target levels, treatment options, and how to adjust your plan during life changes such as college, travel, or pregnancy.

Treatment for Phenylketonuria focuses on keeping blood phenylalanine (often shortened to “Phe”) in a safe range to protect the brain. For most people with Phenylketonuria, this means a lifelong low‑Phe eating plan, using special low‑protein foods and medical formulas that provide the protein and nutrients your body needs without the excess Phe. Doctors sometimes add prescription options such as sapropterin (BH4), pegvaliase for adults, or large neutral amino acids, depending on age, enzyme activity, pregnancy plans, and how well diet alone controls levels. Regular blood tests guide dose changes and diet adjustments, and a metabolic dietitian helps tailor meals, formulas, and medicines to your goals and daily life. Alongside medical treatment, lifestyle choices play a role, including planning ahead for meals, learning label-reading skills, and checking Phe levels more often during growth, illness, or pregnancy.

PKU happens when both copies of a gene that helps your body break down the amino acid phenylalanine don’t work properly. This gene—known medically as PAH—makes an enzyme that processes phenylalanine; when the enzyme is too low or missing, phenylalanine can build up in the blood and brain. PKU appears when a child inherits one nonworking copy from each parent, who are usually healthy and unaware they carry a single change. A “carrier” means you hold the gene change but may not show symptoms. When two carriers have a baby, each pregnancy has a 1 in 4 (25%) chance of PKU, a 1 in 2 (50%) chance the child will be a carrier, and a 1 in 4 chance of neither. Different PAH gene changes can act like a dimmer switch, leading to milder or more severe PKU and shaping how strict treatment needs to be. Because PKU runs in families, genetic testing for PKU and genetic counseling can clarify risks for future pregnancies and whether relatives should consider carrier screening.

Living with Phenylketonuria often means that other health issues can change how well phenylalanine is controlled day to day. Doctors call it a “comorbidity” when two conditions occur together, and common examples with Phenylketonuria include anxiety, depression, and attention difficulties; these can overlap with high phenylalanine effects like brain fog, irritability, or trouble concentrating. When you’re sick with a fever, have an infection, or recover from surgery, the body breaks down more of its own protein, which can push phenylalanine levels up and make thinking or mood symptoms worse; for some, early symptoms of Phenylketonuria can briefly return during these times. Certain medicines or products sweetened with aspartame (which contains phenylalanine) can also raise levels, so treating another condition may require checking inactive ingredients. Women with Phenylketonuria who become pregnant need especially tight control, because high phenylalanine can harm the developing baby even if the mother feels well. If you live with another condition that affects appetite, protein intake, or mental health, coordinated care can help balance the Phenylketonuria diet, medical formula, and any treatments for the other illness.

How genes can cause diseases

Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.

Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.